Thymic stromal lymphopoietin (tslp)-binding molecules and methods of using the molecules

The invention provides molecules, e.g., antibodies or antibody fragments, that specifically bind thymic stromal lymphopoietin (TSLP), compositions comprising these molecules, and methods of using and producing these molecules.

Saved in:
Bibliographic Details
Main Authors Gupta, Kapil, Edwards, Matthew John, Van Heeke, Gino Anselmus, Knopf, Hans-Peter, Andlauer, Barbara, Huang, Daniel, Miller, Danforth, Rondeau, Jean-Michel Rene, Haubst, Nicole, Hemmig, Rene
Format Patent
LanguageEnglish
Published 30.07.2021
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The invention provides molecules, e.g., antibodies or antibody fragments, that specifically bind thymic stromal lymphopoietin (TSLP), compositions comprising these molecules, and methods of using and producing these molecules.
Bibliography:Application Number: NZ20160740067